COOPER, Matthew,MILLER, David,MACLEOD, Angus,VAN WILTENBURG, Jimmy,THOM, Stephen,ST-GALLAY, Stephen,SHANNON, Jonathan
申请号：
SG11201913636W
公开号：
SG11201913636WA
申请日:
2018.07.04
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
The present invention relates to compounds of formula (I) wherein Q is selected from O or S； R1 is a non-aromatic heterocyclic group comprising at least one ring nitrogen atom, wherein R1 is attached to the sulfur atom of the sulfonylurea group by a ring carbon atom, and wherein R1 may optionally be substituted； and R2 is a cyclic group substituted at the α-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
